How are AI-washing risks reshaping digital health M&A due diligence, and what regulatory developments across the U.S., EU, and UK are defining the future of AI-enabled clinical trials, medical devices, and health data governance? This comprehensive update examines the intersection of artificial intelligence, digital health innovation, and evolving compliance frameworks that are transforming healthcare delivery and investment strategies.